GlassScriptPhysician profile
Samia Irfani
NPI 1437326907
$1,058.46
in general payments reported to CMS, 2019-2025
12 companies · $267 in 2025
The $267 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.24 · 2020: $155 · 2021: $101 · 2022: $75.78 · 2023: $187 · 2024: $221 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $443.68 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $164.13 | 2019-2025 | Doc Band |
| Pfizer INC. | $100.11 | 2022-2025 | |
| Sanofi Pasteur INC. | $96.81 | 2024-2025 | |
| Seqirus USA INC | $73.83 | 2024-2025 | Flucelvax |
| Alexion Pharmaceuticals, INC. | $35.71 | 2023 | Strensiq |
| Genentech USA, INC. | $35.61 | 2019-2021 | |
| Genzyme Corporation | $27.69 | 2025 | |
| Hologic Sales and Service, LLC | $23.81 | 2024 | Aptima |
| Merck Sharp & Dohme LLC | $22.95 | 2025 | M-M-R II, Rotateq, Gardasil 9 |
| Phadia US INC. | $20.41 | 2024 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $13.72 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samia Irfani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.